Insider Stock Trading History of Dreyer David C


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Dreyer David C since year 2005. The trader's CIK number is 1203607. At the time of this reporting, Dreyer David C is the SVP / Chief Financial Officer of Biolase Technology Inc . (stock ticker symbol BLTI). See this page for all insider trading activities at Biolase Technology Inc .

Note that in the past DREYER DAVID C also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Dreyer David C since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-07-01 BIOL Biolase Technology Inc Option Ex 70,000 .00 0
2015-11-09 BIOL Biolase Technology Inc Buy 33,000 .77 25,410
2015-09-24 BIOL Biolase Technology Inc Buy 5,000 1.20 6,000
2015-09-22 BIOL Biolase Technology Inc Buy 5,000 1.37 6,850
2015-09-17 BIOL Biolase Technology Inc Buy 10,000 1.45 14,500
2015-06-04 INFU Healthcare Acquisition Partners Corp. Sale 10,000 3.15 31,500
2015-05-29 INFU Healthcare Acquisition Partners Corp. Option Ex 25,000 1.52 38,000
2015-03-25 DPLO Diplomat Pharmacy, Inc. Buy 1,034 29.00 29,986
2014-04-05 INFU Healthcare Acquisition Partners Corp. Option Ex 100,000 2.25 225,000
2014-03-18 PSTX Patient Safety Technologies, Inc Option Ex 416,666 .75 312,499
2011-03-30 PSTX.OB Patient Safety Technologies, Inc Buy 100,000 .75 75,000
2010-12-16 PSTX.OB Patient Safety Technologies, Inc Buy 105,000 .78 81,375
2009-04-12 AHS Amn Healthcare Services Inc Option Ex 12,221 6.41 78,336
2007-11-05 AHS Amn Healthcare Services Inc Sale 350 18.70 6,545
2007-05-12 AHS Amn Healthcare Services Inc Option Ex 6,018 22.62 136,127

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dreyer David C (SVP / Chief Financial Officer of Biolase Technology Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.